Eli Lilly, Zepbound, Tirzepatide, Wegovy, Semaglutide, Obesity, Weight Loss, Weight Management, GLP-1

Indianapolis, Indiana, U.S., September 30, 2026 Eli Lilly and Company announced new findings from an indirect treatment comparison evaluating...